Supplementation of Phosphatidylserine (PS) and n-3 Long Chain Fatty Acids (EPA, DHA) in Children With ADHD

Tel-Aviv Sourasky Medical Center90 enrolled

Overview

To determine whether supplementation of omega-3 long-chain polyunsaturated fatty acid conjugated to phosphatidylserine rather than triglycerides (fish oil) could affect Attention-deficit/hyperactivity disorder symptoms in children.

BACKGROUND Attention-deficit/hyperactivity disorder (ADHD) encompasses a broad constellation of behavioral and learning problems, clinically describes inattentive, impulsive, and/or hyperactive children. These patients are characterized by low blood LC-PUFA (LC-PUFA) levels; however the LC-PUFA supplementation effect on ADHD symptoms is not clear. METHODS Eighty-three ADHD children (3:1 boys:girls), 8-13 years old, were assigned in a randomized, double-blind, placebo-controlled parallel design to receive 250 mg/d of eicosapentaenoic acid + docosahexaenoic acid provided as phosphatidylserine (300 mg/d PS-Omega3), or fish oil or placebo for 3 months. Stimulant medication or other dietary supplements were prohibited. The measured outcomes were inattention and impulsivity, evaluated by Test of Variables of Attention (TOVA) and blood lipids profile.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Attention-Deficit/Hyperactivity Disorder

Interventions

Phosphatidylserine-Omega3DRUG

Eligibility

Sex: ALLMin age: 8 YearsMax age: 13 Years

Medical Language ↔ Plain English

Inclusion Criteria: * 8 and 13 years of age; diagnosed as having ADHD; otherwise healthy; Exclusion Criteria: * significant sensory or neurological limitations, epilepsy, mental retardation, psychosis, or pervasive developmental disorder; medications with known central nervous system effects such as tranquilizers, antidepressants, stimulants (including methylphenidate and amphetamines), sedating antihistamines and some asthma medications and dietary supplements but vitamins

Locations (1)

Clinical Nutrition Unit, Sourasky Medical Center

Tel Aviv, Israel

Outcomes

Primary Outcomes

Laboratory assessment of inattention and impulsivity with Test of Variables of Attention (TOVA)

Blood lipids profile

Secondary Outcomes

Hebrew translation of Conners' Parent Rating Scale-Revised, Short Form

Hebrew translation of the Child Behavior Checklist for Age 4-18, Parent form by Achenbach

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.